Global burden of dementia in younger people: an analysis of data from the 2021 Global Burden of Disease Study

被引:3
|
作者
Li, Ziyi [1 ,2 ,3 ]
Yang, Yucheng [1 ,2 ]
Liu, Yiwen [1 ,2 ]
Wang, Xuechen [1 ,2 ]
Ping, Fan [1 ,2 ]
Xu, Lingling [1 ,2 ]
Zhang, Huabing [1 ,2 ]
Li, Wei [1 ,2 ]
Li, Yuxiu [1 ,2 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Translat Med Ctr, Dept Endocrinol,Key Lab Endocrinol Natl Hlth Commi, 1 Shuaifuyuan, Beijing 100000, Peoples R China
[2] Chinese Acad Med Sci, Diabet Res Ctr, 1 Shuaifuyuan, Beijing 100000, Peoples R China
[3] Capital Med Univ, Xuanwu Hosp, Beijing Inst Geriatr, Dept Endocrinol, Beijing 100053, Peoples R China
基金
中国国家自然科学基金;
关键词
Young-onset dementia; Global burden of disease; Risk factors; Prevalence; Incidence; EARLY-ONSET DEMENTIA; ALZHEIMERS-DISEASE; POPULATION; PREVALENCE; DIAGNOSIS; IMPACT; GENDER; RISK;
D O I
10.1016/j.eclinm.2024.102868
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Dementia among younger people is rapidly emerging as a global health concern; however, comprehensive research on its shifting burden trends remains insufficient. Methods Data on the prevalence, incidence, mortality, and disability-adjusted life years (DALYs) associated with dementia occurring in individuals <70 years were extracted from the Global Burden of Diseases, Injuries, and Risk Factors Study 2021. Average annual percentage changes (AAPCs) were calculated to assess trends in age- specific fi c rates (ASRs), including age-specific fi c prevalence rates (ASPRs), age-specific fi c incidence rates (ASIRs), age- specific fi c mortality rates (ASMRs), and age-specific fi c DALY rates (ASDRs) while young-onset dementia (YOD) burden trends were analyzed. The correlation between ASR/AAPC and the sociodemographic index (SDI) was evaluated. Findings In 2021, the global prevalence of dementia in individuals <70 years increased by 122.33%, with a 128% increase in new cases since 1990. Concurrently, deaths and DALYs of individuals <70 years with dementia rose by 119.28% and 119.77%, respectively. The AAPCs of YOD ASRs during 1990-2021 - 2021 initially increased and then decreased with increasing SDI levels, with the highest AAPCs of ASPR (2.20 [95%CI: 2.08-2.32] - 2.32] per 100,000), ASIR (2.25 [95%CI: 2.06-2.45] - 2.45] per 100,000), ASMR (2.04 [95%CI: 1.93-2.15] - 2.15] per 100,000), and ASDR (2.06 [95%CI: 1.99-2.13] - 2.13] per 100,000) observed in middle-SDI levels. Additionally, females <70 years bore a higher burden of dementia globally, and gender differences are still widening. Interpretation The growth rate of YOD is accelerating, particularly in the middle to high SDI region with females bearing a disproportionately higher burden of YOD. Copyright (c) 2024 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:12
相关论文
共 50 条
  • [21] The Global Burden of Motor Neuron Disease: An Analysis of the 2019 Global Burden of Disease Study
    Park, Jin
    Kim, Jee-Eun
    Song, Tae-Jin
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [22] Global, regional, and national burden of fungal skin diseases in 204 countries and territories from 1990 to 2021: An analysis of the global burden of disease study 2021
    Qin, Qinglian
    Su, Jinming
    Liu, Jie
    Chen, Rongfeng
    Wei, Wudi
    Yuan, Zongxiang
    Lai, Shiyi
    Duan, Ran
    Lai, Jingzhen
    Ye, Li
    Liang, Hao
    Jiang, Junjun
    MYCOSES, 2024, 67 (08)
  • [23] Global, regional and national epidemiological trends of multiple myeloma from 1990 to 2021: a systematic analysis of the Global Burden of Disease study 2021
    Zhuge, Linmin
    Lin, Xiaowu
    Fan, Ziwei
    Jia, Mengxian
    Lin, Chaowei
    Zhu, Minyu
    Teng, Honglin
    Chen, Guoliang
    FRONTIERS IN PUBLIC HEALTH, 2025, 13
  • [24] The burden of chronic kidney disease in Mexico. Data analysis based on the Global Burden of Disease 2021 study
    Argaiz, Eduardo R.
    Morales-Juarez, Linda
    Razo, Christian
    Ong, Liane
    Rafferty, Quinn
    Rincon-Pedrero, Rodolfo
    Gamba, Gerardo
    GACETA MEDICA DE MEXICO, 2023, 159 (06): : 501 - 508
  • [25] The global burden of otitis media in 204 countries and territories from 1992 to 2021: a systematic analysis for the Global Burden of Disease study 2021
    Huang, Guan-Jiang
    Lin, Bao-Rui
    Li, Pei-Shan
    Tang, Na
    Fan, Zhi-Jun
    Lu, Biao-Qing
    FRONTIERS IN PUBLIC HEALTH, 2025, 12
  • [26] Global, regional, and national burden of chronic obstructive pulmonary disease and its attributable risk factors from 1990 to 2021: an analysis for the Global Burden of Disease Study 2021
    Wang, Zhufeng
    Lin, Junfeng
    Liang, Lina
    Huang, Feifei
    Yao, Xiaoyin
    Peng, Kang
    Gao, Yi
    Zheng, Jinping
    RESPIRATORY RESEARCH, 2025, 26 (01)
  • [27] Global, regional, and national burden of esophageal cancer: a systematic analysis of the Global Burden of Disease Study 2021
    Jin, Weiqiu
    Huang, Kaichen
    Ding, Ziyin
    Zhang, Mengwei
    Li, Chongwu
    Yuan, Zheng
    Ma, Ke
    Ye, Xiaodan
    BIOMARKER RESEARCH, 2025, 13 (01)
  • [28] Global, regional, and national burden of gout in elderly 1990-2021: an analysis for the global burden of disease study 2021
    Li, Yilan
    Chen, Zhaopeng
    Xu, Baijie
    Wu, Gengmao
    Yuan, Qiongyu
    Xue, Xiaoqian
    Wu, Yue
    Huang, Yudan
    Mo, Shouqi
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [29] Global, regional and national burden of Glaucoma: an update analysis from the Global Burden of Disease Study 2019
    Chen, Wenli
    Xu, Yi
    Liu, Ziya
    Zhao, Jing
    INTERNATIONAL OPHTHALMOLOGY, 2024, 44 (01)
  • [30] The Global, Regional, and National Burden of Pancreatitis in 204 Countries and Territories, 1990-2021: A Systematic Analysis for the Global Burden of Disease Study 2021
    Liu, Baiqi
    Zhang, Xinge
    Li, Jiarong
    Sun, Zefang
    Lin, Chiayen
    Ning, Caihong
    Hong, Xiaoyue
    Zhu, Shuai
    Shen, Dingcheng
    Chen, Lu
    Huang, Gengwen
    DIGESTIVE DISEASES AND SCIENCES, 2025,